Abstract
Preclinical tests in genetic toxicology represent safety studies. Therefore, the primary concern in the evaluation of Ames test data is the control of the consumer risk, that is, the risk of erroneously concluding safety. Hence, an equivalence test procedure is adequate. This approach is presented beside the two-fold rule and classical tests for differences with respect to an order restricted alternative.
| Original language | English |
|---|---|
| Pages (from-to) | 363-367 |
| Number of pages | 5 |
| Journal | Drug Information Journal |
| Volume | 31 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 30 Dec 1997 |
UN Sustainable Development Goals (SDGs)
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Ames assay
- Consumer risk
- Difference approach
- Equivalence test procedures for ordered many-to-one designs
ASJC Scopus subject areas
- Pharmacology (nursing)
- Drug guides
- Public Health, Environmental and Occupational Health
- Pharmacology (medical)
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver